MICHELE OLLIER

Profile

First Name

: MICHELE

Middle Name

:

Last Name

: OLLIER

Related Companies
Titles
Company Name
Related People
DIRECTOR
NORMOXYS INC
CONRAD BLETZER, JR., CONRAD J. BLETZER, JR., DAVID CLARK, FRANCESCO DE RUBERTIS, DR. JEAN-PIERRE GARNIER, JEAN-PIERRE GARNIER, ARGERIS KARABELAS, JEAN-MARIE LEHN, SARA MCKENZIE, CLAUDE NICOLAU, MARTIN TOLAR
DIRECTOR
AEGERION PHARMACEUTICALS, INC.
DAVID ARKOWITZ, ALISON DE BORD, JASON FISHERMAN, PETER GARRAMBONE, ANTONIO M. GOTTO, ALISON KILEY, WILLIAM H. LEWIS, CHRISTINE PELLIZZARI, WILLIAM SASIELA, DAVID SCHEER
DIRECTOR
LINGUAFLEX, INC.
WILLIAM DOYLE, CLIFF DWYER, MARK FUNSTON, TIMOTHY LANGLOSS, REMY LUTHRINGER, JOHN MICLOT, IRA SANDERS
DIRECTOR
NORMOXYS, INC.
CONRAD BLETZER, JR., CONRAD J. BLETZER, JR., DAVID CLARK, FRANCESCO DE RUBERTIS, DR. JEAN-PIERRE GARNIER, JEAN-PIERRE GARNIER, ARGERIS KARABELAS, JEAN-MARIE LEHN, SARA MCKENZIE, CLAUDE NICOLAU, MARTIN TOLAR
DIRECTOR
MINERVA NEUROSCIENCES, INC.
FRED AHLHOLM, FREDERICK AHLHOLM, MARC BEER, FRANCESCO DE RUBERTIS, HANS PETER HASLER, JERYL HILLEMAN, DAVID KUPFER, FOUZIA LAGHRISSI-THODE, MARK LEVINE, REMY LUTHRINGER, GEOFF RACE, GEOFFREY RACE, JOSEPH REILLY, JAN VAN HEEK, NICO VANDERVELPEN
EXECUTIVE OFFICER
MEDICXI GROWTH I LP
FRANCESCO DE RUBERTIS, DAVID GRAINGER, KEVIN JOHNSON, GIUSEPPE ZOCCO
DIRECTOR
DIASOME PHARMACEUTICALS, INC.
RICHARD CARUSO, BRENDA GAVIN, ROBERT GEHO, W. BLAIR GEHO, W. BLAIR GEHO, DEVANG KANTESARIA, HELGA KAUTSKY, FRANK MCCANEY, THOMAS MCDONALD, COSME ORDONEZ, MARC PENN, LEN ROSENBERG, PETER TOLLMAN, GUISEPPE ZOCCO
EXECUTIVE OFFICER
MEDICXI III LP
FRANCESCO DE RUBERTIS, KEVIN JOHNSON, GIUSEPPE ZOCCO
EXECUTIVE OFFICER
MEDICXI SECONDARY I LP
FRANCESCO DE RUBERTIS, KEVIN JOHNSON
DIRECTOR
PALLADIO BIOSCIENCES, INC.
FRANK CONDELLA, FRANCESCO DERUBERTIS, JOHN ALEXANDER MARTIN, LORENZO PELLEGRINI, MARELLA THORELL, SANFORD ZWEIFACH
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-10-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-24 
2020-09-21
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2020-09-04 
2019-07-10
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2019-06-21 
2017-01-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-12-16 
2016-11-22
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2016-11-08 
2016-03-18
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-03-17 
2016-02-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-15 
2015-03-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-03-18 
2011-11-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-11-07 
2011-06-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-06-10 
2010-06-28
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2008-09-02 
2010-05-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-10 
2010-03-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-21 
2010-02-09
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2008-09-02 
2009-12-30
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-17 
2009-07-15
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2008-09-02 
2009-04-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-22